AI assistant
Gevo, Inc. — Director's Dealing 2015
May 21, 2015
32874_dirs_2015-05-21_6d03dc00-9cf3-4840-adf5-dabc51b4e940.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Gevo, Inc. (GEVO)
CIK: 0001392380
Period of Report: 2015-05-08
Reporting Person: KISHORE GANESH (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-08 | Common Stock | S | 24692 | $5.44 | Disposed | 111429 | Indirect |
| 2015-05-08 | Common Stock | S | 8713 | $5.4987 | Disposed | 102716 | Indirect |
Footnotes
F1: These securities are held by Malaysian Life Sciences Capital Fund Ltd. ("Malaysian Life Sciences"). Ganesh Kishore, Ph.D. is the Chief Executive Officer of Malaysian Life Sciences and may be held to have voting and dispositive power over shares held by the fund. Dr. Kishore disclaims beneficial ownership of shares held by Malaysian Life Sciences except to the extent of his pecuniary interest therein.
F2: Additionally, the reporting person is the direct owner of 146,133 shares of common stock as previously reported on the Form 4 filed on July 1, 2014.